Antonio Cittadini

Specialist in Cardiology, Professor of Internal Medicine at the Federico II University of Naples, Naples, Italy.
Research Fellow in Cardiology and Instructor of Medicine at Harvard Medical School, Boston MA (1993-1997).
Director of the Center for Biomaterials Research (CRIB) of the University of Naples Federico II from 2014 to 2021, and since 2017, President of the Italian Society of Internal Medicine (SIMI) – Campania Section.
Director of the Integrated Activity Department of Internal Medicine and Clinical Complexity, AOU Federico II University of Naples, Naples, Italy.
Director of the Division of Internal Medicine & Metabolism & Rehabilitation, chief of the Cardiology Rehabilitation Gymnasium where projects on heart failure and pulmonary hypertension, coordinated by the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), are conducted.
Chief of the Steering Committee of the Italian Registry of Chronic Heart Failure patients called T.O.S.Ca., which pivotal goal is to evaluate the impact of anabolic deficiencies on the survival of patients with chronic heart failure.
Winner of the Grant for Growth and Innovation, 2016, project title: Treatment of Growth Hormone Deficiency associated with Chronic Heart Failure: A randomized, double-blind, Placebo-controlled study.
Member of the “Campania 3” Ethics Committee.
Director of the Interdepartmental Center for Research in Gender Medicine – GENESIS, Federico II University of Naples.
President elect of AICPR (Italian Association of Clinical, Preventive and Rehabilitative Cardiology.
Author of more than 250 scientific articles in International Indexed Journals (Hirsch Index 54, 10,104 citations) mainly devoted to secondary prevention in post-infarction and chronic heart failure patients.

Responsible for international collaborations focused on the identification of new biomarkers that may improve cardiovascular risk assessment for primary and secondary prevention. Interest in developing cardiovascular prevention strategies in patients with cancer through specific research projects focused on the management of patients with COPD/pulmonary hypertension and diabetes.

Major Research Interests: Endocrine comorbidities in heart failure; Cardiovascular endocrinology; Role of Growth Hormone and Insulin-Like Growth Factor-1 in Cardiovascular Physiology and as Potential Therapeutic Agents in Cardiac Diseases, cardiac rehabilitation, gender medicine.